Table 4

Crude all leukemia rates by initial treatment category (MDS, AML, CML, CLL, ALL)

Treatment category

% (cases/no. in category) (95% CI)


2 years of follow up (n = 5790)


All patients

.45 (26/5790) (.29, .66)


Surgery only

.24 (1/418) (.01, 1.33)


Surgery/radiation

.54 (15/2764) (.30, .89)


Surgery/chemotherapy

.16 (1/640) (.00, .87)


Surgery/radiation/chemotherapy

.46 (9/1968) (.21, 1.64)


5 years of follow up (n = 4179)


All patients

.50 (21/4179) (.31, .77)


Surgery only

.45 (1/220) (.01, 2.51)


Surgery/radiation

.63 (13/2058) (.34, 1.08)


Surgery/chemotherapy

.22 (1/461) (.01, 1.20)


Surgery/radiation/chemotherapy

.42 (6/1440) (.15, .90)


Kaplan et al. BMC Cancer 2011 11:260   doi:10.1186/1471-2407-11-260

Open Data